Hilltop Bio is pleased to announce the official launch of Strydaflex, a revolutionary product in equine joint health. Hilltop Bio produces the most technologically advanced, convenient and consistent room-temperature regenerative therapies available on the market today.
“Because joint issues are one of the most common problems plaguing equine athletes, we've devoted extensive R&D to formulating a joint therapy that not only reduces inflammation, but also helps repair damaged tissue,” said Hilltop Bio CEO, Amanda Drobnis. “We're excited to introduce Strydaflex for equine joints, a game changer for equine veterinarians and their patients. Strydaflex joins our existing line-up of room-temperature regenerative therapies that includes Regenaflex-RT for soft tissue injuries and Regenaflex-M for wounds and surgical implantation.
“As with our other products, Strydaflex is 100% natural and offers the unparalleled convenience of off-the-shelf stability for up to a year, whether that shelf is in your clinic or on your truck.”
Hilltop Bio has completed a pilot safety study on the original cold formulation and is currently conducting a follow up study for the lyophilized version. Initial data indicate that both versions appear to be well tolerated and have demonstrated positive outcomes in horses with clinical lameness.
Traditionally, corticosteroids have been the default treatment for joints because they are great anti-inflammatories. But a large body of evidence indicates that long-term and/or high volume use of corticosteroids can have a serious negative effect on cartilage cells, even to the point of cell death.
“Most of the autologous derived products, whether you're talking about an autologous conditioned serum, an autologous protein solution, PRP; all of those do a really good job of concentrating factors from the blood that you can administer intra-articularly,” said Dr. Dan Dreyfuss. “The problems are (a) you don't know what exactly is in there that's working, and (b) they're also concentrating pro-inflammatory cytokines that you're then putting in the joint. And that's not good for the joint.
“Being able to custom engineer these products for different uses is what, in my opinion, sets Hilltop apart from the rest of the crowd. And it's a really important distinction. Strydaflex has factors in it that are going to take an inflamed synovium, which is over producing pro-inflammatory cytokines, and quiet it down so that the Strydaflex, based on its characterization, is going to incite that synovium to become happier, healthier, and less inflamed. And in the process of doing that, the synovium will produce much better hyaluronic acid within the joint which will contribute to the overall health of the joint.”
Watch Dr. Dan Dreyfuss's full explanation on joint health and Strydaflex here.
The regenerative therapy industry has seen rapid changes in the last two decades. Technological and scientific advancements have empowered veterinarians to provide better care for their patients.
“Most veterinarians are familiar with using stem cell, PRP, IRAP, and ProStride options for soft tissue injuries,” said Drobnis. “What we're seeing in the scientific literature available today is that it's not just the stem cells that fix these injuries; rather it's the exosomes within those stem cells that have the proteins, growth factors, and cytokines as well as the cell-signaling power already available in the horse's body.
“At Hilltop Bio, we're focused on being the leader in the most technologically advanced regenerative therapy market. We're concentrating the exosomes into our formulations to work naturally with the horse's own immune system to up-regulate its healing power and fix itself with minimal scar tissue, reduced inflammation, minimal risk of infection and reduced re-injury rates.
“We're also offering a more consistent product in terms of proteins and growth factors compared to other modalities available on the market today.”
Top veterinarians like U.S. Show Jumping team vets Dr. Tim Ober and Dr. Heather Sherman of Steele & Associates have been using Hilltop products for a number of years.
“We have been using Regenaflex to treat suspensory ligament and check ligament injuries for the past three years,” said Ober. “We are seeing consistency in the healing response with good quality repair, and a much more consistent return to performance than with other regenerative approaches we have used.”
See Hilltop Bio's recent advertorial on Regenaflex-RT and Regenaflex-M here.
The post Hilltop Bio Launches Strydaflex For Equine Joint Health appeared first on Horse Racing News | Paulick Report.
